AbbVie’s Rinvoq rollout on track despite JAK safety concerns, but uncertainty remains: analyst

AbbVie’s Rinvoq rollout on track despite JAK safety concerns, but uncertainty remains: analyst
esagonowsky
Thu, 04/22/2021 – 09:27